Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 148 No. 3738 (2018)

Cardiac resynchronisation therapy in Europe: are Swiss CRT recipients different?

  • Hildegard Tanner
DOI
https://doi.org/10.4414/smw.2018.14670
Cite this as:
Swiss Med Wkly. 2018;148:w14670
Published
23.09.2018

References

  1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al.; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49. doi:.https://doi.org/10.1056/NEJMoa050496
  2. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, et al.; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363(25):2385–95. doi:.https://doi.org/10.1056/NEJMoa1009540
  3. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al.; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA). 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace. 2013;15(8):1070–118. doi:.https://doi.org/10.1093/europace/eut206
  4. Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, et al.; EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med. 2013;369(15):1395–405. doi:.https://doi.org/10.1056/NEJMoa1306687
  5. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, et al., Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med. 2013;368(17):1585–93. doi:.https://doi.org/10.1056/NEJMoa1210356
  6. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146(2):250–7. doi:.https://doi.org/10.1016/S0002-8703(03)00189-3
  7. Dickstein K, Normand C, Auricchio A, Bogale N, Cleland JG, Gitt AK, et al. CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how? Eur J Heart Fail. 2018;20(6):1039–51. doi:.https://doi.org/10.1002/ejhf.1142
  8. Zeljkovic I, Burri H, Breitenstein A, Amman P, Mueller A, Auricchio A, et al. Cardiac Resynchronisation Therapy (CRT) II Survey: CRT implantation in Europe and in Switzerland. Swiss Med Wkly. 2018;148:w14643.doi:.https://doi.org/10.4414/smw.2018.14643
  9. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, et al.; DANISH Investigators. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med. 2016;375(13):1221–30. doi:.https://doi.org/10.1056/NEJMoa1608029
  10. Zusterzeel R, Selzman KA, Sanders WE, Caños DA, O’Callaghan KM, Carpenter JL, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. JAMA Intern Med. 2014;174(8):1340–8. doi:.https://doi.org/10.1001/jamainternmed.2014.2717

Most read articles by the same author(s)